pharmafile_autumn_2020_front_cover

The Autumn 2020 edition of Pharmafile is available to read for free online now!

pharmafile | December 1, 2020 | News story | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing infectious diseases, pharmafile, rare disease, respiratory 

The Autumn 2020 edition of Pharmafile is available to read for free online now!

2020 has seen almost unprecedented disruption for life sciences at the hands of the COVID-19 pandemic. While the industry has somewhat acclimatised and the rollout of an effective vaccine could be around the corner, challenges remain.

The Autumn 2020 edition of Pharmafile aims to bring some clarity to these unprecedented times, bringing together exclusive interviews, the latest R&D developments, and expert opinion to help give a better picture on where the industry is today.

As always, the publication features three key therapeutic areas; this edition focuses on Infectious Diseases, Rare Disease, and Respiratory.

Each section features expert insight from across the industry, with contributors including Janssen, Novartis, Mereo BioPharma and Polphor discussing how the challenges of today can be turned into the opportunities of tomorrow, pandemic or not.

To all our readers, have a great holiday period and New Year!

Click to here to read the edition online.

Related Content

FDA approves first ever treatment for rare CHAPLE disease

The US Food and Drug Administration (FDA) has approved Regeneron’s Veopoz (pozelimab), a new treatment …

genes

AstraZeneca’s Alexion partners with Pfizer for rare disease therapies

Alexion, AstraZeneca’s Rare Disease division, has announced that it has entered a definitive purchase and …

top 10

Pharmafile.com’s top 10 news stories of the week

COVID-19 news has slowed down in the last week, allowing different pharma developments to take …

Latest content